top of page
YT Banner_edited_edited.png
BST

Professor & Program Director of Neurosurgery

YT Banner_edited.png

The Brain Surgeon's Take

New episodes weekly! 

The Brain Surgeon's Take is a discussion based podcast where experts in every field from Nobel Laureates to Navy SEALS to NASA Astronauts to NFL Athletes sit down and talk with world renowned Neurosurgeon and Professor of Neurological Surgery Dr. Rick Komotar.

Dr. Tracy Crane: Alcohol and Cancer Risk – What We Know
25:59

Dr. Tracy Crane: Alcohol and Cancer Risk – What We Know

Dr. Crane is a distinguished leader in cancer control and is passionate about her commitment to the science of better outcomes for patients and community. Her work sits at the intersection of lifestyle medicine and digital health with a goal of developing targeted interventions, utilizing digital biomarkers to deliver the right intervention, at the right time to the right person. She received her Ph.D. from the University of Arizona and is an R25 Transdisciplinary Research on Energetics and Cancer (TREC) NCI Fellow. Dr. Crane was recruited to Sylvester Comprehensive Cancer Center to co-lead the Cancer Control Research Program and direct the Lifestyle Medicine, Prevention and Digital health initiative. She serves on the University of Miami IRB’s consent to contact committee as the Sylvester representative for cancer-related studies and is an appointed cabinet member to the Executive Dean for Research of the Miller School of Medicine. As the population science representative, she serves on the Gynecologic Oncology and Lymphoma site disease groups and works with clinical and research faculty members. She was recently appointed the Vice-Chair for NRG Oncology NCORP Cancer Prevention and Control Committee. Dr. Crane joined Sylvester from the College of Nursing, Biobehavioral Health Sciences Division, at the University of Arizona in Tucson, where she served as co-lead of the Behavioral Measurement and Interventions Shared Resource at the University of Arizona Cancer Center. She also held joint appointments in the Department of Nutrition Sciences, Data Science Institute, and Mel and Enid Zuckerman College of Public Health.
Dr. Robert Hariri: The Evolution of Cellular Medicine
38:44

Dr. Robert Hariri: The Evolution of Cellular Medicine

Dr. Bob Hariri is an accomplished surgeon, biomedical scientist, and serial entrepreneur in two technology sectors, biomedicine and aerospace. He is the chairperson, founder, and chief executive officer of Celularity, Inc., one of the world’s leading human cellular therapeutics companies. Dr. Hariri was the founder and CEO of Anthrogenesis Corporation, and after its acquisition by Celgene Corporation, served as CEO of Celgene Cellular Therapeutics. Dr. Hariri also co-founded the genomic-based health intelligence company, Human Longevity, Inc. Dr. Hariri has served on numerous public boards including Cryoport. Dr. Hariri pioneered the use of stem cells to treat a range of life-threatening human diseases and continues today to make transformative contributions in the fields of immuno-oncology and cell therapeutics along with tissue engineering and functional regeneration. He is widely acknowledged for his discovery of pluripotent stem cells derived from the human placenta, and as a member of the team that discovered the physiological activities of tumor necrosis factor (TNF). Dr. Hariri and his team of scientists were the first to obtain FDA approval to use its cryopreserved allogeneic, off-the-shelf Natural Killer (NK) cell therapy to treat COVID-19 infected adults. He holds over 170 issued and pending patents for discoveries including placenta-derived stem cells, which Nature recognized as one of the ten most important patent estates in the field. He has authored over 150 published chapters, articles, and abstracts.
Joseph Echevarria: Roadmap to UMiami’s New Century.
45:34

Joseph Echevarria: Roadmap to UMiami’s New Century.

As President of the University of Miami and CEO of UHealth, Joe Echevarria leads more than 20,000 professionals whose focus is transforming lives through education, research, and patient care. A seasoned chief executive, Mr. Echevarria served as the CEO of Deloitte LLP, a global provider of professional services, from 2011 until his retirement in 2014. During his 36-year tenure with the firm, he served in various leadership roles, including Deputy Managing Partner, Southeast Region, Audit Managing Partner, and U.S. Managing Partner and Chief Operating Officer. His leadership responsibilities extended to approximately 70,000 professionals in nearly 90 U.S. cities and India, as well as the firm’s US-owned consulting businesses in Germany, Mexico, China, and Brazil. Mr. Echevarria has a long history of service to the University of Miami, where he earned a bachelor’s degree in business administration in 1978. Following his retirement from Deloitte and seven years of service on its Board of Trustees from 2012 to 2019, Echevarria brought his expertise to the University of Miami Health System as a Senior Advisor to former President Julio Frenk, Interim Chief Financial Officer, Chief Administrative Officer, and Interim Chief Executive Officer. He became Chief Executive Officer of UHealth in 2020 and his responsibilities as CEO grew to include the entire University in 2022. On June 12, 2024, the University of Miami Board of Trustees appointed him Acting President of the University.
bottom of page